Procizumab
Procizumab (AK-1967) is a humanized IgG1 antibody that targets dipeptidyl peptidase 3 (DPP3). Procizumab has the potential for the study of sepsis. The isotype control for Procizumab can refer to Human IgG1 kappa, Isotype Control.
Product Specifications
Product Name Alternative
AK-1967
UNSPSC
12352203
Target
Dipeptidyl Peptidase
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
[Procizumab]
References & Citations
[1]Garcia B, et al. Inhibition of circulating dipeptidyl-peptidase 3 by procizumab in experimental septic shock reduces catecholamine exposure and myocardial injury. Intensive Care Med Exp. 2024 Jun 7;12 (1) :53.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
More Discoveries
Explore Other Products
Browse additional items from our catalog
